Leishmania spp.: on the Interactions They Establish with Antigen-Presenting Cells of their Mammalian Hosts, Adv Parasitol, vol.58, pp.1-68, 2004. ,
DOI : 10.1016/S0065-308X(04)58001-6
Challenges and perspectives in vaccination against leishmaniasis, Parasitology International, vol.58, issue.4, pp.319-324, 2009. ,
DOI : 10.1016/j.parint.2009.07.013
Chemotherapy in the Treatment and Control of Leishmaniasis, Adv Parasitol, vol.61, pp.223-274, 2006. ,
DOI : 10.1016/S0065-308X(05)61006-8
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?, Nature Reviews Microbiology, vol.14, issue.11, pp.873-882, 2007. ,
DOI : 10.1038/nrmicro1748
Current scenario of drug development for leishmaniasis, Indian J Med Res, vol.123, pp.399-410, 2006. ,
Advances in leishmaniasis, The Lancet, vol.366, issue.9496, pp.1561-1577, 2005. ,
DOI : 10.1016/S0140-6736(05)67629-5
A guide to drug discovery: Hit and lead generation: beyond high-throughput screening, Nature Reviews Drug Discovery, vol.2, issue.5, pp.369-378, 2003. ,
DOI : 10.1038/nrd1086
Novel Compounds Active against Leishmania major, Antimicrobial Agents and Chemotherapy, vol.50, issue.2, pp.474-479, 2006. ,
DOI : 10.1128/AAC.50.2.474-479.2006
Rapid fluorescent assay for screening drugs on Leishmania amastigotes, Journal of Microbiological Methods, vol.75, issue.2, pp.196-200, 2008. ,
DOI : 10.1016/j.mimet.2008.05.026
Identification of Potent Chemotypes Targeting Leishmania major Using a High-Throughput, Low-Stringency, Computationally Enhanced, Small Molecule Screen, PLoS Neglected Tropical Diseases, vol.8, issue.11, p.540, 2009. ,
DOI : 10.1371/journal.pntd.0000540.s003
Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds, PLoS Neglected Tropical Diseases, vol.73, issue.5, p.675, 2010. ,
DOI : 10.1371/journal.pntd.0000675.s002
URL : https://hal.archives-ouvertes.fr/pasteur-00696809
Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation, Cellular Microbiology, vol.48, issue.7, pp.978-991, 2011. ,
DOI : 10.1111/j.1462-5822.2011.01593.x
URL : https://hal.archives-ouvertes.fr/pasteur-01433560
On image denoising methods, 2004. ,
On detecting all saddle points in 2D images, Pattern Recognition Letters, vol.25, issue.15, pp.1665-1672, 2004. ,
DOI : 10.1016/j.patrec.2004.06.017
Linear-time connected-component labeling based on sequential local operations, Computer Vision and Image Understanding, vol.89, issue.1, pp.1-23, 2003. ,
DOI : 10.1016/S1077-3142(02)00030-9
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays, Journal of Biomolecular Screening, vol.4, issue.2, 1999. ,
DOI : 10.1177/108705719900400206
In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent, Journal of Antimicrobial Chemotherapy, vol.65, issue.3, pp.508-511, 2010. ,
DOI : 10.1093/jac/dkp500
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1, Acta Tropica, vol.51, issue.3-4, 1992. ,
DOI : 10.1016/0001-706X(92)90042-V
Antileishmanial Activity of Three Saponins Isolated from Ivy, ??-Hederin, ??-Hederin and Hederacolchiside A1, as Compared to Their Action on Mammalian Cells Cultured in Vitro, Planta Medica, vol.66, issue.4, pp.343-347, 2000. ,
DOI : 10.1055/s-2000-8541
Mechanisms of resistance toLeishmania aethiopica. I. Interferon-?? in combination with a cytokine (not tumor necrosis factor-??) is required, but cannot act alone in the inhibition of intracellular forms ofL. aethiopica in THP1 cells, European Journal of Immunology, vol.50, issue.9, pp.2331-2337, 1992. ,
DOI : 10.1002/eji.1830220923
In Vitro Sensitivity Testing of Leishmania Clinical Field Isolates: Preconditioning of Promastigotes Enhances Infectivity for Macrophage Host Cells, Antimicrobial Agents and Chemotherapy, vol.53, issue.12, pp.5197-5203, 2009. ,
DOI : 10.1128/AAC.00866-09
In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences, Antimicrobial Agents and Chemotherapy, vol.53, issue.9, pp.3855-3859, 2009. ,
DOI : 10.1128/AAC.00548-09
Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects, Current Pharmaceutical Design, vol.14, issue.21, pp.2061-2074, 2008. ,
DOI : 10.2174/138161208785294636
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?, Microbes and Infection, vol.9, issue.4, pp.529-535, 2007. ,
DOI : 10.1016/j.micinf.2007.01.009
Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nature Reviews Drug Discovery, vol.293, issue.1, pp.29-40, 2007. ,
DOI : 10.1038/nrd2201
Advances and perspectives in Leishmania cell based drug-screening procedures, Parasitology International, vol.56, issue.1, pp.3-7, 2007. ,
DOI : 10.1016/j.parint.2006.09.001
URL : https://hal.archives-ouvertes.fr/hal-00376733
Reporter genes facilitating discovery of drugs targeting protozoan parasites, Trends in Parasitology, vol.25, issue.9, pp.432-439, 2009. ,
DOI : 10.1016/j.pt.2009.06.006
Shuttle mutagenesis and targeted disruption of a telomere-located essential gene of Leishmania, Parasitology, vol.114, issue.04, pp.511-522, 2007. ,
DOI : 10.1038/35071118
Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs, Acta Tropica, vol.122, issue.1, 2011. ,
DOI : 10.1016/j.actatropica.2011.11.015
Fluorescent Leishmania species: Development of stable GFP expression and its application for in vitro and in vivo studies, Experimental Parasitology, vol.127, issue.3, pp.637-645, 2011. ,
DOI : 10.1016/j.exppara.2010.12.006
URL : https://hal.archives-ouvertes.fr/pasteur-00786977
Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo, Parasitology International, vol.58, issue.1, pp.45-50, 2009. ,
DOI : 10.1016/j.parint.2008.09.006
Image-based chemical screening, Nature Chemical Biology, vol.7, issue.8, pp.461-465, 2007. ,
DOI : 10.1038/nchembio.2007.15
A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit, PLoS Neglected Tropical Diseases, vol.129, issue.7, 2011. ,
DOI : 10.1371/journal.pntd.0001253.t001